Sphere Fluidics Successfully Closes a £1.6 Million Investment Round
Sphere Fluidics, an early-stage, Cambridge-based company focusing on developing novel products and services for single cell analysis, has just completed a £1.6 million investment round. The investment syndicate was led by 24Haymarket and included the Royal Society, Cambridge Enterprise Limited, Providence Investment Company Limited, University of Cambridge Enterprise Fund, the London Business Angels Roundtable EIS Fund and a number of individual angels from London (including members of the London Business Angels) and Cambridge. Frank Craig, Sphere Fluidics’ CEO, comments, “We are very pleased to close this round as it gives us the resources to further develop our business. There was strong interest in the company and we were pleased to welcome 24Haymarket into an impressive syndicate of investors. I am excited about further applying our exciting technology to major Life Sciences markets and accelerating its commercialisation”.